NextCure, Inc. (LS:A41AKJ) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of private placement concurrent with the Merger Made bigger: about US$820M Use of proceeds: To advance development of AVR-001 and support future operations of the combined company after the Merger. | Nov 10, 2026 |
| Private placement of shares of common stock and pre-funded warrants Closed: US$21.5M raised · US$8.52 a share · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Buyers: Ikarian Capital; Squadron Capital Management; Affinity Healthcare Fund, LP.; Exome Asset Management; Affinity Healthcare Fund, LP Use of proceeds: General working capital, extending cash runway into first half of 2027, beyond first half 2026 proof of concept data readouts of SIM0505 and LNCB74 | Nov 17, 2025 |